Harry Simeonidis is CEO, President and Director of GBS Inc. Mr. Simeonidis has more than 25 years’ experience in global executive management positions in health care, pharmaceutical and life sciences businesses. His previous roles include CEO of Australia and New Zealand at GE Healthcare and, more recently, General Manager for Surgery Asia Pacific at GE Healthcare. Mr. Simeonidis also serves as Non-Executive Director of FarmaForce, a member company of The iQ Group Global.
Interview with the CEO and the CFO: GBS Inc. (NASDAQ:GBS)
September 30, 2021